These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. Queenan AM, Foleno B, Gownley C, Wira E, Bush K. J Clin Microbiol; 2004 Jan; 42(1):269-75. PubMed ID: 14715764 [Abstract] [Full Text] [Related]
6. Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species. Kohner PC, Robberts FJ, Cockerill FR, Patel R. J Clin Microbiol; 2009 Aug; 47(8):2419-25. PubMed ID: 19494061 [Abstract] [Full Text] [Related]
7. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam? Moland ES, Sanders CC, Thomson KS. J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395 [Abstract] [Full Text] [Related]
8. False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins. Beceiro A, Maharjan S, Gaulton T, Doumith M, Soares NC, Dhanji H, Warner M, Doyle M, Hickey M, Downie G, Bou G, Livermore DM, Woodford N. J Antimicrob Chemother; 2011 Sep; 66(9):2006-10. PubMed ID: 21742679 [Abstract] [Full Text] [Related]